Literature DB >> 10974963

Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial.

L Furniss1, A Burns, S K Craig, S Scobie, J Cooke, B Faragher.   

Abstract

BACKGROUND: Older people in nursing and residential homes often have complex disabilities and behavioural disturbances. Recent publicity has highlighted the dangers of medication in this group, and controls over prescribing have been suggested. AIMS: To investigate the effect of a review of medication by a pharmacist.
METHOD: An 8-month prospective trial of an active medication review by a pharmacist was carried out on 330 residents in nursing homes in Manchester.
RESULTS: The intervention group experienced greater deterioration in cognitive function and behavioural disturbance than the control group, but the changes in depression and quality of life were similar for both groups. The number of drugs prescribed fell in the intervention group, but not in the control group, with a corresponding saving in drug costs. The number of deaths was significantly smaller in the intervention homes during the intervention period (4 v. 14) but not overall during the study period as a whole (26 v. 28).
CONCLUSION: This clinical intervention reduced the number of medicines prescribed to elderly people in nursing homes, with minimal impact on their morbidity and mortality.

Entities:  

Mesh:

Year:  2000        PMID: 10974963     DOI: 10.1192/bjp.176.6.563

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  66 in total

Review 1.  Care of older people: Mental health problems.

Authors:  A Burns; T Dening; R Baldwin
Journal:  BMJ       Date:  2001-03-31

2.  Nursing and residential care for the elderly in Northern Ireland: the contribution of the pharmacist.

Authors:  A K Schweizer; C M Hughes
Journal:  Pharm World Sci       Date:  2001-10

3.  Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study.

Authors:  S Ruths; J Straand; H A Nygaard
Journal:  Qual Saf Health Care       Date:  2003-06

4.  Quality use of medicines in aged-care facilities in Australia.

Authors:  Elizabeth E Roughead; Susan J Semple; Andrew L Gilbert
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Development of a quality use of medicines coding system to rate clinical pharmacists' medication review recommendations.

Authors:  Lene Sorensen; Mendel P Grobler; Michael S Roberts
Journal:  Pharm World Sci       Date:  2003-10

Review 6.  The role of the pharmacist in optimizing pharmacotherapy in older people.

Authors:  Anne Spinewine; Daniela Fialová; Stephen Byrne
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

7.  Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

Authors:  K P G M Hurkens; C Mestres-Gonzalvo; H A J M de Wit; P H M van der Kuy; R Janknegt; F Verhey; J M G A Schols; C D A Stehouwer; B Winkens; W Mulder
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

Review 8.  Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis.

Authors:  S Royal; L Smeaton; A J Avery; B Hurwitz; A Sheikh
Journal:  Qual Saf Health Care       Date:  2006-02

9.  Is medication review by pharmacists of any use?

Authors:  Arnold G Zermansky; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 10.  Is medication review by primary-care pharmacists for older people cost effective?: a narrative review of the literature, focusing on costs and benefits.

Authors:  Arnold G Zermansky; Jonathan Silcock
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.